Fabtech Technologies Limited is a turnkey engineering solutions provider specializing in pharmaceuticals, biotech, and healthcare facilities. The company integrates engineering excellence across pharmaceutical capex projects, contributing significantly to the life sciences space.

The company has demonstrated robust international growth, especially in the MENA and GCC regions, highlighting its strategic expansion focus. This regional focus accounts for a substantial portion of revenue, indicating its critical international market presence.

In partnership with KP Group, Fabtech aims to integrate sustainable solutions into its project offerings, signaling a strategic move towards environmentally conscious engineering practices.

Fabtech's business model is distinctly asset-light and integrates process, air, and water systems in-house to provide comprehensive, compliant, and efficient project solutions, ensuring client reliance and operational efficiency.

The company maintains a strong order book with a noted high-value project acquisition tendency, optimizing revenue visibility and growth through strategic market engagement.